These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 22266302)
1. Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3. Kokotas H; Papagiannaki K; Grigoriadou M; Petersen MB; Katsarou A Eur J Dermatol; 2012; 22(2):182-6. PubMed ID: 22266302 [TBL] [Abstract][Full Text] [Related]
2. Erythrokeratoderma variabilis caused by a recessive mutation in GJB3. Fuchs-Telem D; Pessach Y; Mevorah B; Shirazi I; Sarig O; Sprecher E Clin Exp Dermatol; 2011 Jun; 36(4):406-11. PubMed ID: 21564177 [TBL] [Abstract][Full Text] [Related]
3. Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations. Richard G; Brown N; Rouan F; Van der Schroeff JG; Bijlsma E; Eichenfield LF; Sybert VP; Greer KE; Hogan P; Campanelli C; Compton JG; Bale SJ; DiGiovanna JJ; Uitto J J Invest Dermatol; 2003 Apr; 120(4):601-9. PubMed ID: 12648223 [TBL] [Abstract][Full Text] [Related]
4. Novel and recurrent connexin 30.3 and connexin 31 mutations associated with erythrokeratoderma variabilis. Scott CA; O'Toole EA; Mohungoo MJ; Messenger A; Kelsell DP Clin Exp Dermatol; 2011 Jan; 36(1):88-90. PubMed ID: 21188847 [TBL] [Abstract][Full Text] [Related]
5. A new, recurrent mutation of GJB3 (Cx31) in erythrokeratodermia variabilis. Morley SM; White MI; Rogers M; Wasserman D; Ratajczak P; McLean WH; Richard G Br J Dermatol; 2005 Jun; 152(6):1143-8. PubMed ID: 15948974 [TBL] [Abstract][Full Text] [Related]
6. Molecular interaction of connexin 30.3 and connexin 31 suggests a dominant-negative mechanism associated with erythrokeratodermia variabilis. Plantard L; Huber M; Macari F; Meda P; Hohl D Hum Mol Genet; 2003 Dec; 12(24):3287-94. PubMed ID: 14583444 [TBL] [Abstract][Full Text] [Related]
7. Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4. Zhang X; Xu P; Lu J; Ding Y; Gu J; Shi Y Exp Dermatol; 2022 Apr; 31(4):594-599. PubMed ID: 34717022 [TBL] [Abstract][Full Text] [Related]
8. Expanding the clinical phenotype associated with NIPAL4 mutation: Study of a Tunisian consanguineous family with erythrokeratodermia variabilis-Like Autosomal Recessive Congenital Ichthyosis. Charfeddine C; Laroussi N; Mkaouar R; Jouini R; Khayat O; Redissi A; Mosbah A; Dallali H; Chedly Debbiche A; Zaouak A; Fenniche S; Abdelhak S; Hammami-Ghorbel H PLoS One; 2021; 16(10):e0258777. PubMed ID: 34669720 [TBL] [Abstract][Full Text] [Related]
9. Erythrokeratodermia variabilis et progressiva. Ishida-Yamamoto A J Dermatol; 2016 Mar; 43(3):280-5. PubMed ID: 26945536 [TBL] [Abstract][Full Text] [Related]
10. A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death. Easton JA; Albuloushi AK; Kamps MAF; Brouns GHMR; Broers JLV; Coull BJ; Oji V; van Geel M; van Steensel MAM; Martin PE Exp Dermatol; 2019 Oct; 28(10):1106-1113. PubMed ID: 29570224 [TBL] [Abstract][Full Text] [Related]
13. A novel GJB3 (Cx31) missense mutation in a Chinese patient with erythrokeratodermia variabilis. Wang ZX; Lu WS; Li H; Lin D; Zhou FS; Sun LD; Yang S; Zhang XJ J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):113-5. PubMed ID: 20497287 [No Abstract] [Full Text] [Related]
14. Novel mutation in GJB4 gene (connexin 30.3) in a family with erythrokeratodermia variabilis. Sbidian E; Bousseloua N; Jonard L; Leclerc-Mercier S; Bodemer C; Hadj-Rabia S Acta Derm Venereol; 2013 Mar; 93(2):193-5. PubMed ID: 23037955 [No Abstract] [Full Text] [Related]
15. Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree. de Oliveira RTG; Christofolini DM; Criado PR; Lacaz Martins E; Kelsell D; Machado Filho CDS Int J Dermatol; 2020 Jun; 59(6):722-725. PubMed ID: 32311086 [TBL] [Abstract][Full Text] [Related]
16. Novel and recurrent mutations in GJB3 and GJB4 cause erythrokeratodermia variabilis et progressiva. Dai S; Wang H; Lin Z Indian J Dermatol Venereol Leprol; 2020; 86(1):87-90. PubMed ID: 31793497 [No Abstract] [Full Text] [Related]
17. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Richard G; Smith LE; Bailey RA; Itin P; Hohl D; Epstein EH; DiGiovanna JJ; Compton JG; Bale SJ Nat Genet; 1998 Dec; 20(4):366-9. PubMed ID: 9843209 [TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of GJB3 and GJB4 in Chinese patients with erythrokeratodermia variabilis. Liu H; Liu H; Fu XA; Yu YX; Zhou GZ; Lu XM; Tian HQ; Yu CP; Shi ZX; Yu ML; Zhang FR J Dermatol; 2012 Apr; 39(4):400-1. PubMed ID: 21950330 [No Abstract] [Full Text] [Related]
19. Two de novo GJA1 mutation in two sporadic patients with erythrokeratodermia variabilis et progressiva. Li C; Liang J; Chen P; Zeng K; Xue R; Tian X; Liang L; Wang Q; Shi M; Zhang X Mol Genet Genomic Med; 2019 Jun; 7(6):e670. PubMed ID: 30924322 [TBL] [Abstract][Full Text] [Related]
20. An unusual missense mutation in the GJB3 gene resulting in severe erythrokeratodermia variabilis. Glatz M; van Steensel MA; van Geel M; Steijlen PM; Wolf P Acta Derm Venereol; 2011 Oct; 91(6):714-5. PubMed ID: 21879244 [No Abstract] [Full Text] [Related] [Next] [New Search]